Denmark said Monday it will not include the COVID-19 vaccine from US drugmaker Johnson & Johnson in its national vaccination campaign, citing worries over serious side effects involving blood clots.

"The Danish Health Authority has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect... in those who receive the vaccine," the authority said in a statement.

"Therefore, the Danish Health Authority will continue the Danish mass vaccination programme against COVID-19 without the COVID-19 vaccine from Johnson & Johnson," it added.

The WHO and European medicines watchdog have both authorised the vaccine. 

In mid-April Denmark had also announced that it would stop using the AstraZeneca COVID-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.

Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, Denmark said its vaccination campaign would go ahead without the AstraZeneca vaccine.

Independent journalism costs money. Support Times of Malta for the price of a coffee.

Support Us